Acasti Pharma Inc., of Laval, Quebec, appointed Barry A. Franklin and Robert Hegele to its new scientific advisory board.
Advaxis Inc., of Princeton, N.J., named Al Blunt vice president of medical.
Cellectis SA, of Paris, appointed Catherine Bollard, Hervé Dombret, Ola Landgren, Marcela Maus and Dietger Niederwieser to its clinical advisory board.
Eyegate Pharmaceuticals Inc., of Waltham, Mass., appointed Daniel S. Durrie and Randall J. Olson to its scientific advisory board.
GW Pharmaceuticals plc, of London, appointed Scott Giacobello chief financial officer, and Adam George managing director – UK. Giacobello will be based at the company's U.S. headquarters in Carlsbad, Calif.
Index Pharmaceuticals Holding AB, of Stockholm, appointed Johan Giléus chief financial officer, effective May 1.
Revive Therapeutics Ltd., of Toronto, named Yanlin Wang scientific advisor for cannabinoid-based therapeutics targeting kidney diseases.
Tocagen Inc., of San Diego, appointed Mark Foletta executive vice president and chief financial officer.